MAXR stock was delisted from NYSE on
May 2, 2023. You can explore more stocks from
Technology sector on this page.
DGX Quest Diagnostics Inc
- Stocks
- Healthcare
- NYSE: DGX
Price (delayed)
$171.45
Market cap
$19.14B
P/E Ratio
21.4
Dividend/share
$3.1
EPS
$8.01
Enterprise value
$25.52B
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals
Highlights
Quest Diagnostics's quick ratio has increased by 41% YoY and by 29% QoQ
The gross profit has increased by 9% YoY and by 2.8% from the previous quarter
Quest Diagnostics's debt has increased by 23% YoY but it has decreased by 5% QoQ
DGX's price to earnings (P/E) is 42% higher than its 5-year quarterly average of 15.1 and 8% higher than its last 4 quarters average of 19.9
Key stats
What are the main financial stats of DGX
Market
Valuations
Earnings
Shares outstanding
111.64M
Market cap
$19.14B
Enterprise value
$25.52B
Price to earnings (P/E)
21.4
Price to book (P/B)
2.75
Price to sales (P/S)
1.87
EV/EBIT
18.39
EV/EBITDA
13.4
EV/Sales
2.51
Revenue
$10.16B
Gross profit
$3.34B
Operating income
$1.39B
Net income
$897M
EBIT
$1.39B
EBITDA
$1.91B
Free cash flow
$1.06B
Per share
Balance sheet
Liquidity
EPS
$8.01
EPS diluted
$7.91
Free cash flow per share
$9.51
Book value per share
$62.44
Revenue per share
$91.51
TBVPS
$47.05
Total assets
$15.8B
Total liabilities
$8.84B
Debt
$6.57B
Equity
$6.93B
Working capital
$634M
Debt to equity
0.95
Current ratio
1.44
Quick ratio
1.1
Net debt/EBITDA
3.35
Margins
Efficiency
Dividend
EBITDA margin
18.8%
Gross margin
32.8%
Net margin
8.8%
Operating margin
13.7%
Return on assets
5.8%
Return on equity
13.2%
Return on invested capital
14.8%
Return on capital employed
9.7%
Return on sales
13.7%
Dividend yield
1.81%
DPS
$3.1
Payout ratio
38.7%
DGX stock price
How has the Quest Diagnostics stock price performed over time
Intraday
-1.25%
1 week
-3.09%
1 month
-3.38%
1 year
22.07%
YTD
13.65%
QTD
-4.55%
Financial performance
How have Quest Diagnostics's revenue and profit performed over time
Revenue
$10.16B
Gross profit
$3.34B
Operating income
$1.39B
Net income
$897M
Gross margin
32.8%
Net margin
8.8%
DGX's operating income is up by 11% year-on-year and by 3.4% since the previous quarter
The gross profit has increased by 9% YoY and by 2.8% from the previous quarter
The revenue has grown by 9% YoY and by 2.9% from the previous quarter
The net income has grown by 6% YoY and by 3% from the previous quarter
Price vs fundamentals
How does DGX's price correlate with its fundamentals
Growth
What is Quest Diagnostics's growth rate over time
Valuation
What is Quest Diagnostics stock price valuation
P/E
21.4
P/B
2.75
P/S
1.87
EV/EBIT
18.39
EV/EBITDA
13.4
EV/Sales
2.51
DGX's price to earnings (P/E) is 42% higher than its 5-year quarterly average of 15.1 and 8% higher than its last 4 quarters average of 19.9
DGX's EPS is up by 6% year-on-year and by 3% since the previous quarter
The stock's price to book (P/B) is 10% more than its last 4 quarters average of 2.5 and 6% more than its 5-year quarterly average of 2.6
Quest Diagnostics's equity has increased by 8% YoY and by 2.2% from the previous quarter
The stock's price to sales (P/S) is 10% more than its 5-year quarterly average of 1.7 and 3.9% more than its last 4 quarters average of 1.8
The revenue has grown by 9% YoY and by 2.9% from the previous quarter
Efficiency
How efficient is Quest Diagnostics business performance
Quest Diagnostics's return on invested capital has decreased by 10% YoY and by 4.5% QoQ
DGX's return on assets is down by 6% year-on-year
Dividends
What is DGX's dividend history
DPS
$3.1
Dividend yield
1.81%
Payout ratio
38.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Quest Diagnostics financials performed over time
The total assets is 79% greater than the total liabilities
The current ratio has increased by 48% YoY and by 31% QoQ
Quest Diagnostics's quick ratio has increased by 41% YoY and by 29% QoQ
Quest Diagnostics's debt is 5% lower than its equity
Quest Diagnostics's debt has increased by 23% YoY but it has decreased by 5% QoQ
The company's debt to equity rose by 14% YoY but it fell by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.